This notice exempts a director or senior manager of a listed issuer from disclosing relevant interests in quoted financial products if—

• the financial products are the managed investment products of an index-tracking fund; or

• the financial products of the listed issuer are approved for trading on a financial product market that is authorised to operate in Australia or the United Kingdom. The exemption is subject to the conditions that the director or senior manager discloses the interests under the listing rules of that in Australia or the United Kingdom (the overseas market), or the law and regulatory requirements of the jurisdiction in which the overseas market operates, and that information is disclosed to a licensed market operator for the purpose of making the information available to participants in the relevant New Zealand financial product market. In addition, the exemption is subject to a condition that the relevant interest is noted in an interests register that is kept in accordance with the Financial Markets Conduct Act 2013 (the Act).

This notice continues the exemptions under the Financial Markets Conduct (Disclosure of Relevant Interests by Directors and Senior Managers) Exemption Notice 2019, which is revoked at the close of 30 November 2024. This notice comes into force on 1 December 2024 and is revoked at the close of 30 November 2029.

The Financial Markets Authority (the FMA), after satisfying itself as to the matters set out in section 557 of the Act, considers it appropriate to grant the exemption because—

• the exemptions under the Financial Markets Conduct (Disclosure of Relevant Interests by Directors and Senior Managers) Exemption Notice 2019 are still applicable for market participants and have been in place under earlier notices since 3 May 2004; and

• the risk of insider trading or any other market manipulation is minimal for quoted financial products that are interests in index-tracking funds; and

• without an exemption, directors and senior managers holding relevant interests in quoted managed investment products of index-tracking funds would be subject to disclosure obligations that would raise unnecessary practical compliance issues for the directors and senior managers concerned; and

• compliance with the disclosure regime would, in the case of relevant interests in quoted managed investment products of index-tracking funds, not provide information that is likely to further the market information or anti-insider trading purposes of the disclosure regime; and

• disclosure under the Act in respect of the financial products of a listed issuer where disclosure is made under the listing rules of an overseas market or the law or regulatory requirements of the jurisdiction in which the overseas market operates, and which has been further disclosed to NZX Limited or another licensed market operator, would be an unnecessary duplication of disclosure requirements; and

• the granting of the exemptions is desirable in order to promote the purposes of the Act, specifically by avoiding unnecessary compliance costs and to provide for timely, accurate, and understandable information to be provided to the market to assist market participants in making decisions. The exemptions are not broader than is reasonably necessary to address the matters that gave rise to the exemptions.